Shunji Hirose

<p>Safety and Efficacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis</p>

Katsuaki Ogushi, Makoto Chuma, Haruki Uojima et al. · Clinical and Experimental Gastroenterology · 2020 · 53 citations · Full text

Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma

Makoto Chuma, Haruki Uojima, Kazushi Numata et al. · Cancers · 2020 · 51 citations · Full text

Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis

Makoto Chuma, Haruki Uojima, Nobuhiro Hattori et al. · Hepatology Research · 2021 · 50 citations

Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis

Makoto Chuma, Haruki Uojima, Atsushi Hiraoka et al. · Hepatology Research · 2020 · 38 citations

Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients

Shunji Hirose, Koshi Matsumoto, Masayuki Tatemichi et al. · PLoS ONE · 2020 · 37 citations · Full text